BFG
TMCI icon

Bleakley Financial Group’s Treace Medical Concepts TMCI Stock Holding History

Bleakley Financial Group’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,469
Closed -$77.9K – 954
2024
Q4 		$77.9K Sell
10,469
-11,673
-53% -$78.1K ﹤0.01% 1000
2024
Q3 		$128K Sell
22,142
-58,794
-73% -$378K ﹤0.01% 954
2024
Q2 		$538K Buy
+80,936
New +$654K 0.02% 592

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bleakley Financial Group's TMCI Position: Q1 2025 in Review

Bleakley Financial Group sold out of Treace Medical Concepts (TMCI) in Q1 2025, closing a stake of 10,469 shares — an estimated $77.9K sold.

Bleakley Financial Group first reported a position in TMCI in Q2 2024 and held it in 3 quarters. The position peaked at $538K in Q2 2024. 138 funds tracked by Wall St. Rank hold TMCI as of Q1 2025.

  • Bleakley Financial Group reported no remaining Treace Medical Concepts position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 10,469 Treace Medical Concepts shares in Q1 2025, an estimated $77.9K.
  • Bleakley Financial Group first reported a position in Treace Medical Concepts in Q2 2024 and held it in 3 quarters.
  • Bleakley Financial Group's Treace Medical Concepts position peaked at $538K in Q2 2024.
  • 138 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.